Stoic Venture Capital

We are in the midst of technological shifts at a pace faster than ever before. Calculus VC capitalizes on these shifts to deliver returns and impact. We invest in the Series A and Series B stages of startups in the below sectors: FUTURE OF COMPUTING AND AI Continued advancements in AI will demand new developments in hardware and software. New computing materials and interfaces may emerge. Computing power may be more distributed, and the world will be infinitely more connected. These and more, are our areas of interest: Intelligence beyond language: We expect AI to understand quantitative models and physical phenomenon just as well as it understands language. Large Quantitiative Models are a focus for us. New hardware, materials, and architectures: We expect that demand for computing power will grow exponentially. Quantum computing, as well as distributed computing are expected to grow. We expect advancements in computing materials beyond silicon. Immersive and neural interfaces: These interfaces already exist, we expect they will become more mainstream. Spatial computing, integrating the physical world with digital environments may be our future. COMPUTATIONAL LIFE SCIENCES AND HEALTHTECH Breakthroughs in biology, materials, sensors, and data science are converging to redefine healthcare. Precision and personalization will take center stage as AI enhances how we detect, monitor, and treat disease. Areas of interest include: AI-First Therapeutics and Discovery Platforms: ML-powered platforms designing drugs and biologics via simulation, predictive modeling, and data-rich experimentation. Infrastructure for Programmable Biology: Tools that make biology engineerable – lab automation, bioinformatics, 3D bioprinting, next-gen diagnostics and R&D devices. Continuous, Data-Driven and Personalized Care: Wearables, medical devices, and diagnostics to deliver patient-centric care. These models turn users into real-time data streams, enabling adaptive treatment and personalized interventions. ADVANCED INDUSTRIAL TECHNOLOGIES As we expand the frontiers of possibility, we expect industry to evolve with intelligence, autonomy and environmental sustainability at its core. Areas of focus include: AI and automation in industry: Intelligent machines will optimize production, reduce waste, and enable new workflows. From predictive maintenance to robotic manufacturing, automation will power the next industrial revolution. We support startups enabling this vision. Land, ocean, and space transport and communications: We are interested in advanced materials, robotics, sensors, systems and software that will unlock new frontiers from deep-sea mapping to planetary missions. Resource efficiency: Building the future will demand large reserves of energy and natural resources. Technologies that can serve our energy, food, water, and agricultural needs while supporting a better planet are of interest to us.

LiquidMetal Ventures is a newly established venture capital fund based in Boston, aiming at investing in early-stage (Seed, Angel, and pre-A round) in a minority group, particularly deep-tech startups. LiquidMetal Ventures is based on deep-tech start-up communities and has a unique advantage in reaching out to ‘off-the-market’ early-stage deals and cooperating with peer VC funds tightly to reduce the risk, overall a high return could be expected. LiquidMetal Ventures focuses on biotech and healthcare, carbon neutrality, AI and data, infrastructure, and consumer tech. There is a huge tide of startups among Boston entrepreneurs in the US on the way. We would like to be the first to check VC with the founders. Investment FocusBioTech Medical Device Sustainability AI & Data Science Advanced Energy Technology Robotics & Advanced Manufacturing

Molten Ventures is Europe’s largest listed tech VC firm. We inject the most visionary companies with energy to help them transform and grow. This energy comes in many forms - capital of course but also knowledge, experience, relationships, and commitment. For our portfolio, for our investors and for our society, we make more possible. We invest in companies for the long term, but we start from early stage, so we have chosen a name that captures that very first change. When a solid becomes a liquid, it becomes Molten. We transformed venture capital In helping our portfolio transform, so too have we. Our public listing and multi-fund model allow us to provide entrepreneurs with a more flexible approach to funding, to back the best teams for as long as they need and give investors the ability to share in the growth of the companies that are inventing the future. We are global The best entrepreneurs will take their companies beyond Europe. We are part of a global community of independent funds that can help them scale across the world. We invest in Europe’s best tech companies Molten Ventures portfolio of investments boasts 67 companies includes exciting early-stage companies like Irish drone delivery company Manna Aero, Cambridge-based quantum computing software company, Riverlane, London-based climate intelligence company, Cervest and Finnish satellite company ICEYE. As a testament to its ability to support companies throughout their lifecycle, Molten’s portfolio also includes European unicorns like Trustpilot, UiPath, Graphcore, Revolut, Cazoo, Ledger and Aircall.

We are investors in the B2B and Enterprise Space. Built in India for the World: Cloud-based, enterprise-first digital companies being built in India and focused on global markets. ESG-Positive: Fintech, Healthtech, Mobility, Cleantech and Agritech companies for aspirational India​ and other markets. Emerging Technologies: Backing companies and entrepreneurs in breakout areas (deep tech, space tech, web3, AR/VR etc.) for the next decade. We pride ourselves in being the investor our portfolio founders value most on their cap table, with equalamounts of constructive challenge and unconditional support. With our Morphosis 3/6 Acceleration Model, we source and supercharge growth for the right investment opportunities. We are investing in proprietary technology that our portfolio companies can leverage to accelerate growth while also allowing our funds to source and screen investment opportunities more meaningfully.

We have invested in more than 90 companies since 2016, including Pinterest, Compass, Hippo, Ro, Carta, Dutchie, Anduril, Varda Space Industries, Ghost, Front, Esusu, OKCredit, and Unqork. Additionally, through our subsidiary fund, New Slate Ventures, we have financed films, documentaries, and limited series that have been acquired by Apple, Netflix, and Disney. Based in New York City, we invest globally. Backstory Sinai Capital Partners was founded in 2017. We raised $100 million and built a talented team of young investors with offices in New York, Palo Alto, and Los Angeles. We made over 90 investments, realized 11 exits, and achieved a 1X return on our first fund within two years. In 2019, we raised $100 million for a subsidiary of Sinai Capital called New Slate Ventures, with the goal of supplying the many players in the streaming wars with independent content. Our films, series, and documentaries won Academy Award nominations, Golden Globes, Grammy’s, and Emmy’s, and were acquired by the likes of Apple, Disney, and Netflix for multiples of their cost. As a solo GP, I believe boutique, disciplined, early-stage funds with effective managers will generate the best returns for investors in this forthcoming innovation cycle. Throughout my career I’ve nurtured relationships across Silicon Valley, Wall Street, Washington DC, and Hollywood, and aim to leverage this access on behalf of the founders I support. Where to Now? We’re currently in the midst of the greatest acceleration of technological progress since 2010 and the advent of mobile/social computing. New frameworks for problem solving are emerging daily aided by artificial intelligence, CRISPR technologies, climate manipulation, and several other radical new fields previously dismissed as science fiction. When we started Sinai, the prevailing wisdom in Silicon Valley was that “hardware was hard” and that software investments provided much better risk-adjusted opportunities. That assumption is becoming less credible in the current venture capital landscape, with space exploration, brain computer interfaces, driverless electric vehicles, autonomous warfare drones, and nuclear fusion companies all appearing to be increasingly within reach, with potentially transformational impacts on civilization. Sinai’s new focus will be on these harder technical problems, as we believe this is where the majority of the value creation for this next venture cycle will emerge. While we still welcome revenue generating SaaS businesses, its become clearer to us that the best returns come from the most non-obvious ideas in undefined markets and categories. Some of our latest investments include Anduril, Varda, Galvanick, Rangeview, Factory.AI, Science.IO, and several others. We seek to invest in 5-10 companies each year, with average check sizes ranging between $1-5M depending on stage. We’re happy to lead seed rounds where we have high conviction, but prefer to collaborate with our friends at top funds across the globe. We are geographically agnostic, but are most active in New York, San Francisco, Miami, London, and the South Bay of Los Angeles.

We are a European family office owned fund; we understand biosciences and medical technologies better than anyone else in the Private Equity and Venture Capital ecosystem. The capital of this fund has been generated by the family office's active bioscience investments across Europe, USA, and the APAC region since 1995. We understand the intricacies of commercializing bioscience discoveries. We also acknowledge that bioscience venture leadership requires deep courage - from founders and the investors that back them. What we look for We operate globally and only review investment opportunities submitted to us by our partner investment banks across the globe. If we believe in the transformative power of the discovery and the founder's ambition, this will suffice for us to determine the venture's potential. Our approach Upon receipt of a proposal from our investment bank partners, we will analyze the proposed deal, meet with the venture founders, and understand their vision. We will propose a deal size and structure. Execute a letter of intent and perform appropriate due diligence, negotiate, and execute a mutually acceptable binding contract. Release the required funding, close the transaction and work together to grow the business.